From Humble Beginnings to Eastern India’s Leading Diagnostics Brand: The Story of Nirnayan Healthcare
From Humble Beginnings to Eastern India’s Leading Diagnostics Brand: The Story of Nirnayan Healthcare In 2018, brothers Subhra Kanti Saha and Abhra Kanti Saha, hailing from a family of doctors, observed a gap in the Eastern India healthcare landscape. Special medical tests were often outsourced to larger cities, causing delays and inconvenience for patients. This realization sparked an entrepreneurial journey that would transform into Nirnayan Healthcare, one of the region’s most respected and accredited pathology brands today.
Leaving Comfort, Embracing Innovation
Despite holding engineering degrees and successful careers in multinational companies, the brothers made a bold decision. They dropped out of their MBA programs and left their high-paying jobs to pursue their vision. With a humble investment of Rs 10-12 lakh, they established a 200-square-foot laboratory in their hometown of Kolkata.
Building a B2B Powerhouse
Nirnayan Healthcare initially focused on the B2B market, serving hospitals primarily in tier 2 and 3 cities. They collected blood samples, processed them efficiently, and delivered accurate and timely reports. Their commitment to quality and service helped them expand their clientele to tier 1 cities and establish themselves as a trusted partner for various healthcare providers.
From 22 Patients to 4,000 Samples: A Growth Story
The initial days were marked by dedication and perseverance. Starting with just 22 patients on their first day, Nirnayan now processes over 4,000 samples daily, a testament to their remarkable growth trajectory.
Leading the Way During the Pandemic
The COVID-19 pandemic presented unique challenges, but Nirnayan Healthcare rose to the occasion. By leveraging automation and advanced technologies, the brothers significantly expedited testing processes and played a crucial role in serving the community during this critical time.
Recognition and Expansion
Nirnayan’s dedication to quality earned them the prestigious National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation in 2019. This recognition, coupled with their commitment to innovation and expansion, has seen their footprint grow to a 15,000 square foot laboratory with a team of over 400 employees.
Financial Success and Future Aspirations
Nirnayan Healthcare demonstrates impressive financial growth, consistently achieving 40-50% year-on-year growth. They aim to reach Rs 200 crore in revenue within the next two years, with their current asset value standing at Rs 50 crore and a market value of Rs 150 crore. The ambitious brothers envision establishing over 50 labs across India in the next five years.
The Brothers at the Helm: A Shared Vision, Distinct Roles
Subhra Kanti Saha, the Co-founder and Co-CEO, oversees business development and information technology. His leadership has been instrumental in streamlining operations and minimizing errors, ensuring the most accurate reports with the shortest turnaround time.
Abhra Kanti Saha, the other Co-founder and Co-CEO, leads the technical, operational, and finance wings. Under his guidance, Nirnayan has acquired cutting-edge technologies, solidifying their position as a leader in Eastern India’s medical diagnostics landscape.
Beyond Business: Social Impact and a Commitment to Quality
Nirnayan Healthcare believes in giving back to the community. They offer affordable testing services in rural areas and organize health camps to promote preventive healthcare. Their commitment to quality and innovation ensures that patients in Eastern India have access to timely and accurate medical diagnoses, empowering them to make informed healthcare decisions.
Nirnayan Healthcare, a story of vision, dedication, and unwavering commitment to excellence, exemplifies the power of innovation and social responsibility in shaping the future of healthcare in Eastern India.